The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden
Open accessAbstract
BACKGROUND: The American Cancer Society, the National Cancer Institute, the North American Association of Central Cancer Registries (NAACCR), the National Institute on Aging (NIA), and the Centers for Disease Control and Prevention, including the National Center for Health Statistics (NCHS) and the National Center for Chronic Disease Prevention and Health Promotion, collaborated to provide an annual update on cancer occurrence and trends in the United States. This year's report contained a special feature focusing on implications of age and aging on the U.S. cancer burden. METHODS: For 1995 through 1999, age‐specific rates and age‐adjusted rates were calculated for the major cancers using incidence data from the Surveillance, Epidemiology, and End Results Program, the National Program of Cancer Registries, and the NAACCR, and mortality data from NCHS. Joinpoint analysis, a model of joined line segments, was used to examine 1973–1999 trends in incidence and death rates by age for the four most common cancers. Deaths were classified using the eighth, ninth, and tenth revisions of the International Classification of Diseases. Age‐adjusted incidence and death rates were standardized to the year 2000 population, which places more emphasis on older persons, in whom cancer rates are higher. RESULTS: Across all ages, overall cancer death rates decreased in men and women from 1993 through 1999, while cancer incidence rates stabilized from 1995 through 1999. Age‐specific trends varied by site, sex, and race. For example, breast cancer incidence rates increased in women aged 50‐64 years, whereas breast cancer death rates decreased in each age group. However, a major determinant of the future cancer burden is the demographic phenomenon of the aging and increasing size of the U.S. population. The total number of cancer cases can be expected to double by 2050 if current incidence rates remain stable. CONCLUSIONS: Despite the continuing decrease in cancer death rates and stabilization of cancer incidence rates, the overall growth and aging of the U.S. population can be expected to increase the burden of cancer in our nation. Cancer 2002;94:2766–92. © 2002 American Cancer Society. DOI 10.1002/cncr.10593
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,781
Self-citationPermutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
International Statistical Classification of Diseases and Related Health Problems
(2011) · Encyclopedia of Clinical Neuropsychology · doi:10.1007/978-0-387-79948-3_3055 · Cited by 4,151
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,174
International Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
Tarver, T. (2013) · Journal of Consumer Health On the Internet · doi:10.1080/15398285.2013.756760 · Cited by 1,038
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
Lewis, J. H., Kilgore, M. L., Goldman, D. P., Trimble, E. L., Kaplan, R., Montello, M. J., Housman, M. G., & Escarce, J. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.010 · Cited by 1,031
DePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951
Management of Cancer in the Older Person: A Practical Approach
Balducci, L., & Extermann, M. (2000) · The Oncologist · doi:10.1634/theoncologist.5-3-224 · Cited by 939
Kim, H. (2001) · Statistics in Medicine · doi:10.1002/sim.811 · Cited by 873
Ries, L. A. G., Wingo, P. A., Miller, D. S., Howe, H. L., Weir, H. K., Rosenberg, H. M., Vernon, S. W., Cronin, K., & Edwards, B. K. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000515)88:10<2398::aid-cncr26>3.0.co;2-i · Cited by 743
Self-citationHowe, H. L., Wingo, P. A., Thun, M. J., Ries, L. A. G., Rosenberg, H. M., Feigal, E. G., & Edwards, B. K. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.824 · Cited by 738
Self-citationAge standardization of death rates: implementation of the year 2000 standard.
Anderson, R. N., & Rosenberg, H. M. (1998) · PubMed · Cited by 612
Self-citation(2001) · PubMed · Cited by 612
Wingo, P. A., Ries, L. A. G., Giovino, G. A., Miller, D. S., Rosenberg, H. M., Shopland, D. R., Thun, M. J., & Edwards, B. K. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.8.675 · Cited by 582
Self-citationBreen, N., Wagener, D. K., Brown, M. L., Davis, W. W., & Ballard-Barbash, R. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1704 · Cited by 502
The Aging of America: Impact on Health Care Costs
Schneider, E. L. (1990) · JAMA · doi:10.1001/jama.1990.03440170057036 · Cited by 439
Feldman, J. J., Kleinman, J. C., Makuc, D. M., Mościcki, E. K., Pierre, M. B., & Wagener, D. K. (1989) · Cited by 397
Cancer incidence and mortality, 1973-1995: A report card for the U.�S.
Wingo, P. A., Ries, L. A. �., Rosenberg, H. M., Miller, D. S., & Edwards, B. K. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980315)82:6<1197::aid-cncr26>3.0.co;2-0 · Cited by 392
Self-citation(2000) · PubMed · Cited by 371
Representation of older patients in cancer treatment trials
Trimble, E. L., Cain, D., Ungerleider, R. S., Friedman, M. A., Carter, C. L., & Freidlin, B. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-# · Cited by 343
Quality of death rates by race and Hispanic origin: a summary of current research, 1999.
Rosenberg, H. M., Maurer, J. D., Sorlie, P. D., Johnson, N. J., MacDorman, M. F., Hoyert, D. L., Spitler, J. F., & Scott, C. W. (1999) · PubMed · Cited by 289
Self-citationPerspectives on Comorbidity and Cancer in Older Patients: Approaches to Expand the Knowledge Base
Yancik, R., Ganz, P. A., Varricchio, C. G., & Conley, B. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1147 · Cited by 284
Self-citationVital Statistics Rates in the United States: 1900-1940.
Densen, P. M., Linder, F. E., Grove, R. D., & Dunn, H. L. (1944) · Journal of the American Statistical Association · doi:10.2307/2280634 · Cited by 281
General guidelines for the management of older patients with cancer.
Balducci, L., & Yates, J. (2000) · PubMed · Cited by 275
Longevity and Medicare Expenditures
Lubitz, J., Beebe, J., & Baker, C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321506 · Cited by 251
Vital statistics rates in the United States, 1940-1960
Grove, R. D., & Hetzel, A. M. (1968) · U.S. Government Printing Office eBooks · Cited by 191
International trends in prostate-cancer mortality in the ?PSA era?
Oliver, S. E., May, M. T., & Gunnell, D. (2001) · International Journal of Cancer · doi:10.1002/ijc.1260 · Cited by 181
Health, United States, 1999; with health and aging chartbook
Kramarow, E. A., Lentzner, H. R., Saydah, S., Weeks, J. D., & Rooks, R. N. (1999) · University of Michigan Library Repository · Cited by 181
The 1990 Post-Enumeration Survey: Operations and Results
Hogan, H. (1993) · Journal of the American Statistical Association · doi:10.1080/01621459.1993.10476374 · Cited by 168
Aging and Cancer: Issues of Basic and Clinical Science
Ershler, W. B., & Longo, D. L. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.20.1489 · Cited by 152
Stanfield, R. L. (1996) · PubMed · Cited by 130
The American Cancer Society challenge goals
Byers, T., Mouchawar, J., Marks, J. S., Cady, B., Lins, N., Swanson, G. M., Bal, D. G., & Eyre, H. J. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990815)86:4<715::aid-cncr22>3.0.co;2-o · Cited by 112
Aging and Cellular Senescence.
Fujiwara, Y. (1995) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.32.259 · Cited by 109
Baraldi-Junkins, C. A., Beck, A. C., & Rothstein, G. (2000) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70277-x · Cited by 105
The changing face of cancer survivorship
Rowland, J. H., Aziz, N. M., Tesauro, G., & Feuer, E. J. (2001) · Seminars in Oncology Nursing · doi:10.1053/sonu.2001.27912 · Cited by 84
Life span extension and cancer risk: myths and reality
Anisimov, V. V. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00114-0 · Cited by 80
Comparability of the death certificate and the 1986 National Mortality Followback Survey.
Poe, G. S., Powell‐Griner, E., McLaughlin, J. K., Placek, P. J., Gb, T., & Robinson, K. (1993) · PubMed · Cited by 78
Trends, Issues, Perspectives, and Values for the Aging of the Baby Boom Cohorts
Cornman, J. M., & Kingson, E. R. (1996) · The Gerontologist · doi:10.1093/geront/36.1.15 · Cited by 75
Pharmacology of antineoplastic agents in older cancer patients.
Lichtman, S. M., & Skirvin, J. A. (2000) · PubMed · Cited by 62
Pharmacology of antineoplastic agents in older cancer patients
Lichtman, S. M., Skirvin, J. A., & Vemulapalli, S. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00120-8 · Cited by 51
Older Age — Not a Barrier to Cancer Treatment
Muss, H. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200110113451512 · Cited by 48
Kennedy, B. J. (2000) · PubMed · Cited by 47
MOLECULAR INTERACTIONS OF CANCER AND AGE
Fernandez‐Pol, J. A., & Douglas, M. G. (2000) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70276-8 · Cited by 23
Analysis of comfort care for the terminally ill: the hospice approach.
West, J. P., & Cm, W. (1998) · PubMed · Cited by 1
Cited by
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Self-citationEdwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Self-citationAnnual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
Jemal, A., Ward, E. M., Johnson, C. J., Cronin, K. A., Ma, J., Ryerson, A. B., Mariotto, A., Lake, A. J., Wilson, R., Sherman, R. L., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx030 · Cited by 1,556
Self-citationAnnual Report to the Nation on the Status of Cancer, part I: National cancer statistics
Cronin, K. A., Lake, A. J., Scott, S., Sherman, R. L., Noone, A., Howlader, N., Henley, S. J., Anderson, R. N., Firth, A. U., Ma, J., et al. (2018) · Cancer · doi:10.1002/cncr.31551 · Cited by 1,485
Self-citationCapecitabine as Adjuvant Treatment for Stage III Colon Cancer
Twelves, C., Wong, A., Nowacki, M. P., Abt, M., Burris, H., Carrato, A., Cassidy, J., Cervantes, A., Fagerberg, J., Georgoulias, V., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043116 · Cited by 1,248
Metadata
- Authors
- Edwards, B. K., Howe, H. L., Ries, L. A. G., Thun, M. J., Rosenberg, H. M., Yancik, R., Wingo, P. A., Jemal, A., & Feigal, E. G.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2002-05-14
- Volume
- 94
- Issue
- 10
- Pages
- 2766-2792
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2009443603
- Cited by
- 880
- References
- 47
- FWCI
- 31.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.